Innospec vs Ingevity: revenue, profit, margins and growth compared
Innospec brought in $1.8B of revenue in fiscal 2025, Ingevity $1.2B in fiscal 2025. Revenue changed by -3.7% at Innospec and -2.7% at Ingevity on the year before, so Ingevity grew faster. Innospec kept 6.6% of its revenue as net profit, Ingevity -14.3%. Free cash flow was $88M at Innospec and $273.5M at Ingevity.
Fiscal years as each company reports them; the two may end in different months.
Questions about Innospec and Ingevity
Which is bigger by revenue, Innospec or Ingevity?
Innospec is bigger by revenue: $1.8B in fiscal 2025, against $1.2B for Ingevity in fiscal 2025.
Which keeps more of its revenue as profit, Innospec or Ingevity?
Innospec had a net margin of 6.6% in fiscal 2025; Ingevity had -14.3% in fiscal 2025.
Which grew revenue faster, Innospec or Ingevity?
In their latest fiscal years revenue changed by -3.7% at Innospec and -2.7% at Ingevity.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.